Natural Capsules Ltd Share Price Today - Natural Capsules Ltd Stock Price Live NSE/BSE

Natural Capsules Ltd

NSE: NATCAPSUQ BSE: 524654

₹151

(-0.10%)

Wed, 18 Mar 2026, 00:02 pm

MTF 5xInvest in Natural Capsules Ltd with 5x Leverage Buy with MTF

Market Cap1.56B

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Other

24.5K

Natural Capsules Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
153.72
Net Profit
0.62
P/B
0.82
Sector P/E
31.82
P/E
307
EV/EBITDA
15.74
Debt/Equity (Industry)
0.23
Interest Cover (Industry)
9.79
ROCE (Industry)
12.90
RONW (Industry)
12.30
ROE
0.28
ROCE
2.86
Debt/Equity
0.49
EPS (TTM)
0
Dividend Yield
0
Book Value
218.35
Interest Cover
1.43

Analysis

all

Pros

Dividends paid are well covered by earnings (2.4x coverage).
Natural Capsules's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
Natural Capsules is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Natural Capsules is profitable, therefore cash runway is not a concern.
Natural Capsules is profitable, therefore cash runway is not a concern.

Cons

Dividends per share have fallen over the past 10 years.
Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
Natural Capsules's dividend is below the markets top 25% of dividend payers in India (3.08%).
The level of debt compared to net worth has increased over the past 5 years (11.5% vs 13.9% today).
Interest payments on debt are not well covered by earnings (EBIT is 1.5x annual interest expense, ideally 3x coverage).

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	51.26	51.26	51.26	51.21	51.14
FII	0	0	0	0	0
DII	0	0	0	0	0
Public	48.74	48.74	48.74	48.79	48.86
Government	0	0	0	0	0

Technical Analysis

RSI

37.90

MACD

-4.19

50 DMA

163.56

200 DMA

198.75

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	246.29	205.29	179.58	164.29	138.58	123.29	82.29
Fibonacci	205.29	189.63	179.95	164.29	148.63	138.95	123.29
Camarilla	165.15	161.39	157.63	164.29	150.11	146.35	142.59

Pivots Level: Classic

+82

246.29

+41

205.29

+15.29

179.58

164.29

Pivot Point

LTP: 147.37

-25.71

138.58

-41

123.29

-82

82.29

Moving Average

SMAEMA

Period

Value

10-EMA
150.49
20-EMA
153.40
30-EMA
156.45
50-EMA
162.45
100-EMA
174.85
200-EMA
189.05

Announcement Date	Purpose	Action	Ex Date
13 Feb 2026	board-meetings	Quarterly Results
13 Nov 2025	board-meetings	Quarterly Results
10 Jul 2025	agm
26 Jul 2024	egm
02 Jul 2024	agm
04 Jul 2023	agm
26 May 2023	dividend	₹1.00 Dividend /Share	20 Jul 2023
26 Aug 2022	agm
10 May 2022	dividend	₹1.00 Dividend /Share	13 Sept 2022
01 Nov 2021	rights	1:2 Rights Issue of Equity Shares	12 Nov 2021

Natural Capsules Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd

Lupin Ltd

Divis Laboratories Ltd

Natural Capsules Ltd About

Natural Capsules is a wellequipped modern manufacturing plant to manufacture Hard Gelatin Capsule shells, Hard Cellulose Capsule shells and Pharmaceutical Dosage Forms in Capsule .Dosage Form.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1993

Headquarters

CEO

T Y Prabhu

Employees

Contact

Website

http://www.naturalcapsules.com

company.sec@naturalcapsules.com; info@naturalcapsu

Phone

91-080-26671571/26671573/26671581

Location

Trident Towers 4th Floor No 23, 100Feet Road Jayanagar IIBlock, Bangalore, Karnataka, 560011

Year	History
2013	The company recommended dividend at 15% on the equity shares of Rs. 10/- each.
2014	The company recommended dividend at 15% on the equity shares of Rs. 10/- each.
2015	Natural Capsules acquired 40% shares from Supreem Pharmaceuticals Mysore Pvt Ltd. Natural Capsules added an exclusive manufacturing line for HPMC vegetarian capsules. Natural Capsules boosted manufacturing capacity of Gelatin capsules at its Pondicherry unit.
2021	The company issued rights shares of 1:2 at a premium of Rs. 90 per share.
2024	The Company commenced commercial production in High Speed HPMC Line.

Client Name	Order Side	QTY	Avg Price	Date
SMIT RAJESHBHAI GADHIYA	Sell	70300	164.73	06 Mar 2026
TARINIKA MANAGEMENT LLP	Buy	335400	164.75	06 Mar 2026
SMIT RAJESHBHAI GADHIYA	Sell	256000	164.9	06 Mar 2026
SMIT RAJESHBHAI GADHIYA	Buy	70329	149	05 Mar 2026
SMIT RAJESHBHAI GADHIYA	Buy	256010	148.62	05 Mar 2026
TARINIKA MANAGEMENT LLP	Sell	329471	148.8	05 Mar 2026
BYTES AND PIXELS FINSOFT LLP .	Sell	67409	279.61	26 Sept 2025
BYTES AND PIXELS FINSOFT LLP .	Buy	43675	273.78	26 Sept 2025
BYTES AND PIXELS FINSOFT LLP .	Buy	102153	258.86	25 Sept 2025
BYTES AND PIXELS FINSOFT LLP .	Sell	78419	259.77	25 Sept 2025

Natural Capsules Ltd News

Natural Capsules Gets Credit Rating Reaffirmation

Natural Capsules Limited receives reaffirmed credit ratings from Infomerics Valuation and Rating Limited for facilities worth Rs. 59.15 crore, with BB+(Stable) for long-term and A4+ for short-term facilities.

17 Mar 2026

companies

Natural Capsules subsidiary signs manufacturing deal

Natural Biogenex Private Limited, material subsidiary of Natural Capsules Limited, enters framework and contract manufacturing agreement with Fermbox Bio Private Limited involving Rs. 60 crores investment.

12 Mar 2026

companies

Natural Capsules Reports Q3 FY25 Financial Results

Natural Capsules Limited announces Q3 FY25 results with total income of ₹122.98 crore and net profit of ₹49.33 crore. Company also reports nine-month performance data.

15 Feb 2026

finance general

Natural Capsules Q3FY26 Results Show Operational Challenges

Natural Capsules reported revenue of ₹37.75 crore in Q3FY26, down 18% QoQ and 14% YoY. EBITDA turned negative at ₹(2.33) crore with margins at (6.16%). Puducherry unit shutdown impacted operations.

13 Feb 2026

co actions results

Natural Capsules Gets High Court Relief on Plant Closure

Natural Capsules Limited receives Madras High Court order suspending drug controller's temporary plant closure directive, allowing resumption of Pondicherry manufacturing operations.

30 Jan 2026

stocks

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800